On this page
Trogarzo
ibalizumab-uiyk
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Trogarzo
Proper name
ibalizumab-uiyk
Licence type
351(a)
BLA number
761065
Applicant
Theratechnologies Inc.
Center
CDER
Presentations
1
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 200MG/1.33ML (150MG/ML) | Injection | Intravenous | Single-Dose Vial | Rx | March 6, 2018 |
Exclusivity
Source: Purple Book| Kind | Expires |
|---|---|
| Orphan exclusivity | March 6, 2025 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |